Si-Bone

Yahoo Finance • 7 hours ago

Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Shares of Harmonic Inc(NASDAQ:HLIT) rose sharply in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates. Also, the company raised its FY26 EP... Full story

Yahoo Finance • 2 days ago

SI-BONE Posts Double-Digit Q1 Growth, Raises 2026 Guidance; Stock Up

(RTTNews) - SI-BONE, Inc. (SIBN) reported financial results for the first quarter ended March 31, 2026, showing double-digit revenue growth and improved profitability metrics compared to the prior year. First Quarter 2026 Results Worldwi... Full story

Yahoo Finance • 23 days ago

SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026

SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report fi... Full story

Yahoo Finance • 2 months ago

Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers”

SI-BONE, Inc. (NASDAQ:SIBN) is one of the stocks Jim Cramer answered questions about. Inquiring about the stock, a caller mentioned that it has declined around 30% since they last asked about it in January. In response, Cramer said: Gee,... Full story

Yahoo Finance • 3 months ago

Smith+Nephew signs distribution agreement with SI-BONE

Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today ann... Full story

Yahoo Finance • 5 months ago

SI-Bone added to ‘Conviction List’, named ‘2026 Top Pick’ at Needham

Needham analyst David Saxon raised the firm’s price target on SI-Bone (SIBN) to $27 from $24 and keeps a Buy rating on the shares. The firm has also added the stock to its ‘Conviction List’, replacing Alcon (ALC) and named it Needham’s ‘20... Full story

Yahoo Finance • 6 months ago

Galvanize Therapeutics Appoints Laura Francis to its Board of Directors

REDWOOD CITY, Calif., Nov. 24, 2025 /PRNewswire/ -- Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today ann... Full story

Yahoo Finance • 6 months ago

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandle... Full story

Yahoo Finance • 6 months ago

SI-BONE Inc. Q3 Loss Declines

(RTTNews) - SI-BONE Inc. (SIBN) reported Loss for third quarter of -$4.57 million The company's bottom line totaled -$4.57 million, or -$0.11 per share. This compares with -$6.58 million, or -$0.16 per share, last year. The company's re... Full story

Yahoo Finance • 6 months ago

SI-BONE outlines 18%–20% revenue growth target for 2025 with platform expansion, eyes positive free cash flow in 2026

Earnings Call Insights: SI-BONE, Inc. (SIBN) Q3 2025 MANAGEMENT VIEW * Laura Francis, CEO, reported "another quarter of robust revenue growth, achieved sustained adjusted EBITDA profitability and reached a major milestone in delivering... Full story

Yahoo Finance • 6 months ago

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (allcomparisons are to the prior year period) Worldwide revenue of $4... Full story

Yahoo Finance • 7 months ago

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the third quarter of 2025 afte... Full story

Yahoo Finance • 8 months ago

KLIC Crosses Above Average Analyst Target

In recent trading, shares of Kulicke & Soffa Industries, Inc. (Symbol: KLIC) have crossed above the average analyst 12-month target price of $40.60, changing hands for $41.13/share. When a stock reaches the target an analyst has set, the... Full story

Yahoo Finance • 9 months ago

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanl... Full story

Yahoo Finance • 9 months ago

Factbox-Russian energy export disruptions since start of Ukraine war

(Reuters) -When U.S. President Donald Trump meets Russian President Vladimir Putin on Friday, one of his bargaining chips to encourage Putin to make progress toward a ceasefire in Ukraine will be to ease U.S. sanctions on Russia’s energy i... Full story

Yahoo Finance • 9 months ago

SI-BONE’s SWOT analysis: stock poised for growth amid market challenges

SI-BONE, Inc. (NASDAQ:SIBN), a medical device company specializing in minimally invasive solutions for sacroiliac joint disorders, has been making significant strides in the orthopedic sector. The company’s innovative approach to addressin... Full story

Yahoo Finance • 9 months ago

SI-BONE stock price target reiterated at $25 by Cantor Fitzgerald

Investing.com - Cantor Fitzgerald has reiterated an Overweight rating and $25.00 price target on SI-BONE Inc. (NASDAQ:SIBN) following the company’s second-quarter 2025 financial results. According to InvestingPro data, analyst targets for... Full story

Yahoo Finance • 9 months ago

Dunn, director at Si-Bone, sells $5,090 in SIBN stock

Jeffrey W. Dunn, a director at SI-BONE, Inc. (NASDAQ:SIBN), sold 293 shares of common stock on August 4, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The transaction comes as the medical device company’s... Full story

Yahoo Finance • 9 months ago

SI-BONE raises 2025 revenue guidance to $195M-$198M with accelerated cash flow milestones

Earnings Call Insights: SI-BONE, Inc. (SIBN) Q2 2025 MANAGEMENT VIEW * CEO Laura A. Francis highlighted that "We had a record number of U.S. physicians perform our procedures this quarter, reinforcing the expanding reach and clinical a... Full story

Yahoo Finance • 9 months ago

SI-BONE INC (NASDAQ:SIBN) Posts Mixed Q2 2025 Earnings with Revenue Slight Miss but EPS Beat Drives Positive Market Reaction

SI-BONE INC (NASDAQ:SIBN [https://www.chartmill.com/stock/quote/SIBN/profile]) REPORTS Q2 2025 EARNINGS: MIXED RESULTS BUT MARKET REACTION POSITIVE SI-BONE INC released its second-quarter 2025 financial results, delivering a mixed perform... Full story